99 related articles for article (PubMed ID: 2532481)
21. Solubilization of human platelet vasopressin receptors.
Thibonnier M
Life Sci; 1987 Feb; 40(5):439-45. PubMed ID: 3807642
[TBL] [Abstract][Full Text] [Related]
22. Relationship between vasopressin and renal concentrating ability in aging rats.
Geelen G; Corman B
Am J Physiol; 1992 May; 262(5 Pt 2):R826-33. PubMed ID: 1590476
[TBL] [Abstract][Full Text] [Related]
23. Hormonal regulation of rat testicular arginine vasopressin receptors.
Kasson BG; Tuchel TL
Endocrinology; 1989 Jun; 124(6):2777-84. PubMed ID: 2498062
[TBL] [Abstract][Full Text] [Related]
24. G protein coupling of human platelet V1 vascular vasopressin receptors.
Thibonnier M; Goraya T; Berti-Mattera L
Am J Physiol; 1993 May; 264(5 Pt 1):C1336-44. PubMed ID: 8498489
[TBL] [Abstract][Full Text] [Related]
25. Nature and properties of human platelet vasopressin receptors.
Vittet D; Rondot A; Cantau B; Launay JM; Chevillard C
Biochem J; 1986 Feb; 233(3):631-6. PubMed ID: 3010940
[TBL] [Abstract][Full Text] [Related]
26. Study of V1a vasopressin receptor gene single nucleotide polymorphisms in platelet vasopressin responsiveness.
Hasan KN; Shoji M; Tsutaya S; Kudo R; Matsuda E; Saito J; Kimura T; Yasujima M
J Clin Lab Anal; 2006; 20(3):87-92. PubMed ID: 16721832
[TBL] [Abstract][Full Text] [Related]
27. Radioimmunoassay of plasma vasopressin in physiological and pathological states in man.
Beardwell CG; Geelen G; Palmer HM; Roberts D; Salamonson L
J Endocrinol; 1975 Nov; 67(2):189-202. PubMed ID: 1206269
[TBL] [Abstract][Full Text] [Related]
28. Physiological regulation of the renal vasopressin receptor-effector pathway in dogs.
Kinter LB; Caldwell N; Caltabiano S; Winslow C; Brooks DP; Huffman WF
Am J Physiol; 1990 Mar; 258(3 Pt 2):R763-9. PubMed ID: 2138428
[TBL] [Abstract][Full Text] [Related]
29. Effects of arginine vasopressin (AVP) infusions on circulating concentrations of platelet AVP, factor VIII: C and von Willebrand factor.
Nussey SS; Bevan DH; Ang VT; Jenkins JS
Thromb Haemost; 1986 Feb; 55(1):34-6. PubMed ID: 3085262
[TBL] [Abstract][Full Text] [Related]
30. Serum Vasopressinase and Platelet Responses to Arginine Vasopressin in Normal Pregnancy, Pregnancy-induced Hypertension and Pre-eclampsia.
Gordge MP; Robson SC; Williams DJ; Payne NN; Neild GH
Platelets; 1994; 5(2):90-5. PubMed ID: 21043609
[TBL] [Abstract][Full Text] [Related]
31. Modulation of vasopressin actions on human platelets by plasma adenosine and theophylline: gender differences.
Agarwal KC
J Cardiovasc Pharmacol; 1993 Jun; 21(6):1012-8. PubMed ID: 8336506
[TBL] [Abstract][Full Text] [Related]
32. Effects of amiloride analogues on AVP binding and activation of V1-receptor-expressing cells.
Thibonnier M; Bayer AL; Simonson MS; Douglas JG
Am J Physiol; 1992 Jan; 262(1 Pt 1):E76-86. PubMed ID: 1733254
[TBL] [Abstract][Full Text] [Related]
33. Plasma vasopressin and human neurophysins in physiological and pathological states associated with changes in vasopressin secretion.
Pullan PT; Clappison BH; Johnston CI
J Clin Endocrinol Metab; 1979 Oct; 49(4):580-7. PubMed ID: 479348
[TBL] [Abstract][Full Text] [Related]
34. Characterization of a specific, high affinity [3H]arginine8 vasopressin-binding site on liver microsomes from different strains of rat and the role of magnesium.
Gopalakrishnan V; Triggle CR; Sulakhe PV; McNeill JR
Endocrinology; 1986 Mar; 118(3):990-7. PubMed ID: 3004905
[TBL] [Abstract][Full Text] [Related]
35. Radioimmunoassay of arginine vasopressin in the plasma and urine.
Srámková J; Horký K; Dvoráková J
Physiol Bohemoslov; 1979; 28(5):399-409. PubMed ID: 160049
[TBL] [Abstract][Full Text] [Related]
36. [Radioimmunological determination of plasma antidiuretic hormone (arginine-vasopressin or AVP): results in normal subjects].
Salomez-Granier F; Racadot A; Lefebvre J; Linquette M
Lille Med; 1979 Dec; 24(10):805-11. PubMed ID: 529967
[No Abstract] [Full Text] [Related]
37. Specific receptors for vasopressin in the pituitary gland: evidence for down-regulation and desensitization to adrenocorticotropin-releasing factors.
Koch B; Lutz-Bucher B
Endocrinology; 1985 Feb; 116(2):671-6. PubMed ID: 2981673
[TBL] [Abstract][Full Text] [Related]
38. Identification and characterization of vascular (V1) vasopressin receptors of an established smooth muscle cell line.
Stassen FL; Heckman G; Schmidt D; Aiyar N; Nambi P; Crooke ST
Mol Pharmacol; 1987 Mar; 31(3):259-66. PubMed ID: 2951584
[TBL] [Abstract][Full Text] [Related]
39. [Recent progress in vasopressin research on cardiovascular diseases].
Shoji M; Yasujima M
Rinsho Byori; 2007 Jun; 55(6):544-8. PubMed ID: 17657988
[TBL] [Abstract][Full Text] [Related]
40. Vasopressin-mediated forearm vasodilation in normal humans. Evidence for a vascular vasopressin V2 receptor.
Hirsch AT; Dzau VJ; Majzoub JA; Creager MA
J Clin Invest; 1989 Aug; 84(2):418-26. PubMed ID: 2527249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
